An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus
Clinical trial NCT04810754 · UNKNOWN
Trial details
- NCT number
- NCT04810754
- Sponsor
- Charite University, Berlin, Germany
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2023-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.